Court hands Novartis win in Gilenya patent fight; US states seek $26B+ in opioid crisis lawsuit
Novartis has picked up a win in a long-running patent fight against generic versions of its multiple sclerosis drug.
The company announced Monday afternoon that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
